CAS号:75438-57-2
品名:莫索尼啶Moxonidine
中文别名:莫索尼定,不带盐酸;4-氯-N-(4,5-二氢-1H-咪唑-2-基)-6-甲氧基-2-甲基-5-嘧啶胺;莫索尼定;
英文别名:Lomox;Norcynt;[14C]-Moxonidine;4-chloro-5-[(4,5-dihydro-1H-imidazol-2-yl)-amino]-6-methoxy-2-methylpyrimidine;Moxonidinum[Latin];4-chloro-5-(imidazoline-2-ylamino)-6-methoxy-2-methylpyrimidine;BE5895;Moxonidine;Cynt;MOXONIDINE;Nucynt;Physiotens;4-chloro-N-(4,5-dihydro-1H-imidazol-2-yl)-6-methoxy-2-methyl-5-pyrimidinamine;4-chloro-N-(4,5-dihydro-1H9imidazol-yl)-6-methoxy-2-methyl-5-pyrimidinamine;Normoxocin;[3H]-Moxonidine;
分子式:C9H12ClN5O
分子量:241.677
精确质量:241.073
Psa:71.43
RTECS号:UV6260290
MDL号:MFCD22689455
外观与性状:晶体
密度:1.52 g/cm3 (20ºC)
沸点:364.7ºC at 760 mmHg
熔点:40-43°C(lit.)
闪点:&>230°F
折射率:1.68
储存条件:Store in original container in a cool dark place.
WGK Germany:3
简介:Moxonidine(INN)isanew-generationcentrallyactingantihypertensivedruglicensedforthetreatmentofmildtomoderateessentialhypertension.Itmayhavearolewhenthiazides,beta-blockers,ACEinhibitorsandcalciumchannelblockersarenotappropriateorhavefailedtocontrolbloodpressure.Inaddition,itdemonstratesfavourableeffectsonparametersoftheinsulinresistancesyndrome,apparentlyindependentofbloodpressurereduction.ItismanufacturedbySolvayPharmaceuticalsunderthebrandnamePhysiotens.
用途:通过刺激中枢突触前α2-受体而起效。其降压效果和钙拮抗剂硝苯地平和ACE抑制剂卡托普利相似。用于原发性高血压。
其他分子